Chemomab Therapeutics Ltd. is a clinical-stage biopharmaceutical company incorporated in 2011, focused on designing and developing targeted treatments for inflammation and fibrosis. Its lead product candidate, nebokitug (CM-101), is an antagonist of CCL24 signaling and is in clinical development for primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company has no approved products and has not generated revenue. It has conducted four clinical trials and holds Orphan Drug Designation for nebokitug in three indications.
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2023-03-20 | 2022-12-31 | 0001178913-23-001041 | EDGAR | 80K words |
| 2022-03-30 | 2021-12-31 | 0001178913-22-001304 | EDGAR | — |
| 2021-03-09 | 2020-12-31 | 0001104659-21-033822 | EDGAR | — |
| 2020-03-17 | 2019-12-31 | 0001104659-20-034835 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2023-05-11 | 2023-03-31 | 0001178913-23-001807 | EDGAR | 10K words |
| 2022-11-10 | 2022-09-30 | 0001178913-22-003931 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001178913-22-003074 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001178913-22-001919 | EDGAR | — |
| 2021-11-12 | 2021-09-30 | 0001178913-21-003509 | EDGAR | — |
| 2021-08-13 | 2021-06-30 | 0001178913-21-002696 | EDGAR | — |
| 2021-05-13 | 2021-03-31 | 0001104659-21-065588 | EDGAR | — |
| 2020-11-16 | 2020-09-30 | 0001104659-20-125523 | EDGAR | — |
| 2020-08-14 | 2020-06-30 | 0001104659-20-095149 | EDGAR | — |
| 2020-05-07 | 2020-03-31 | 0001104659-20-058143 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2023-06-16 | 0001178913-23-002225 | EDGAR | 1K words |
| 2023-06-05 | 0001178913-23-002136 | EDGAR | 2K words |
| 2023-05-11 | 0001178913-23-001809 | EDGAR | 3K words |
| 2023-02-21 | 0001178913-23-000679 | EDGAR | 1K words |
| 2023-02-21 | 0001178913-23-000670 | EDGAR | 13K words |
| 2023-01-11 | 0001178913-23-000147 | EDGAR | 1K words |
| 2023-01-03 | 0001178913-23-000010 | EDGAR | 1K words |
| 2022-11-16 | 0001178913-22-004061 | EDGAR | — |
| 2022-11-14 | 0001178913-22-004019 | EDGAR | — |
| 2022-08-12 | 0001178913-22-003072 | EDGAR | — |
142 total filings indexed. 118 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001534248 |
| Ticker | CMMB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L3 |
| Website | https://www.chemomab.com |
| Listed | 2021-03-17 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CMMB (~200 tokens, structured JSON with cryptographic provenance)